Helping young adults who inject drugs get treated for hepatitis C with partner support
A Randomized Trial to Test the Efficacy of a Partner Navigation Intervention for HCV Treatment among Young Adult People who Inject Drugs
This study is looking at how young adults under 30 who use injectable drugs can get better help for hepatitis C by involving their partners in the treatment process, making it easier for them to support each other and improve their chances of getting well.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11060976 on NIH RePORTER |
What this research studies
This research investigates how young adults under 30 who inject drugs can receive better treatment for hepatitis C by involving their injecting partners in the process. The study focuses on overcoming barriers to treatment through a Partner Navigation Intervention, which includes two sessions aimed at enhancing the support and cooperation between partners. By leveraging interpersonal trust and emotional support, the intervention seeks to improve the likelihood of successful treatment for hepatitis C among this vulnerable population.
Who could benefit from this research
Good fit: Ideal candidates for this research are young adults aged 21 and under who inject drugs and are at risk for hepatitis C.
Not a fit: Patients who do not inject drugs or are over the age of 30 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase the number of young adults who inject drugs receiving effective treatment for hepatitis C.
How similar studies have performed: Previous research has shown promise in using partner support to improve health outcomes in similar populations, indicating that this approach may be effective.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Morris, Meghan D — University of California, San Francisco
- Study coordinator: Morris, Meghan D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.